What is Transchem share price return in the past 10 years?

Transchem Ltd share price has appreciated 5.9% annually (CAGR) over the past ten years.

Transchem Ltd - Stock Valuation and Financial Performance

Name: Transchem
Brand: Transchem

BSE: 500422 | NSE: TRANSCHEM | Agriculture | Small Cap

Place order

Transchem Share Price

₹38.95 0.36 0.93%
as on 14-Nov'24 16:59

DeciZen - make an informed investing decision on Transchem

Based on:

Data

M-Cap below 100cr DeciZen not available

Transchem stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

8.73

Market Cap:

48 Cr.

52-wk low:

52-wk high:

50.7

Is Transchem Ltd an attractive stock to invest in?

1. Is Transchem Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Transchem Ltd is a below average quality company.

2. Is Transchem Ltd undervalued or overvalued?

The key valuation ratios of Transchem Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Transchem Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Transchem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Transchem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	0.3%	0.1%	-0.6%	-1.5%	2.1%	2.1%	49.7%	6.1%	3.8%	8%	-
Value Creation Index ⓘ	-1.0	-1.0	-1.0	-1.1	-0.9	-0.9	2.6	-0.6	-0.7	-0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	22.5	0	0	0.4	0
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	-100%	NA	NA	-
Adj EPS ⓘ	0.1	-0.9	-1.1	-1.5	0.1	0.3	19.7	2.3	1	3.4	4.5
YoY Gr.	-	-1010%	NA	NA	NA	135.7%	5878.8%	-88.1%	-56.8%	239.6%	-
BVPS (₹) ⓘ	31.3	31.4	31	30.1	31	30	51.4	54.2	53.8	61.8	63.2
Adj Net Profit ⓘ	0.1	-1.1	-1.3	-1.8	0.2	0.4	24.2	2.9	1.2	4.2	5
Cash Flow from Ops. ⓘ	0.9	1.1	0.6	-19.8	10.3	-0.6	-27.7	21.9	1.2	-39.3	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	-73.7%	NA
Adj EPS ⓘ	48.1%	89.6%	-44.2%	239.6%
BVPSⓘ	7.8%	14.8%	6.3%	14.9%
Share Price	5.9%	24.5%	28.1%	43.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	0.3	-2.9	-3.4	-4.9	0.4	1.1	48.5	4.4	1.9	5.9	7.2
Op. Profit Mgn % ⓘ	0	0	0	0	0	0	91.4	0	0	-423.4	-110.5
Net Profit Mgn % ⓘ	0	0	0	0	0	0	107.5	0	0	1025.2	1340.4
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	0	0	0	0	0	0	457	0	0	40,246	3,695
Cash Conv. Cycle ⓘ	0	0	0	0	0	0	1	0	0	183	3,669

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 7.20%

Sales growth has been subdued in last 3 years -73.67%

Net Profit has been subdued in last 3 years -44.19%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Transchem Ltd.

	Standalone	Consolidated
TTM EPS (₹)	4.5	-
TTM Sales (₹ Cr.)	0.4	-
BVPS (₹.) ⓘ	63.2	-
Reserves (₹ Cr.) ⓘ	65	-
P/BV ⓘ	0.62	-
PE ⓘ	8.73	-

From the Market
52 Week Low / High (₹)	25.01 / 50.69
All Time Low / High (₹)	2.55 / 95.00
Market Cap (₹ Cr.)	48
Equity (₹ Cr.)	12.2
Face Value (₹)	10
Industry PE ⓘ	43.8

Management X-Ray of Transchem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Transchem

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Transchem

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	0	0	0	0	0	0	22.46	0	0	0.41
Operating Expenses ⓘ	0.89	0.93	0.98	1.69	1.35	1.39	1.94	2.74	1.73	2.15
Manufacturing Costs	0	0	0	0.05	0	0.01	0.23	0	0	0
Material Costs	0	0.01	0.01	0	0	0	0	0	0	0.40
Employee Cost	0.23	0.28	0.28	0.24	0.44	0.62	0.71	0.75	0.78	0.75
Other Costs ⓘ	0.66	0.64	0.70	1.40	0.92	0.76	1	1.99	0.95	0.99
Operating Profit ⓘ	-0.89	-0.93	-0.98	-1.69	-1.35	-1.39	20.52	-2.74	-1.73	-1.74
Operating Profit Margin (%)	-	-	-	-	-	-	91.4%	-	-	-423.0%
Other Income ⓘ	2.09	1.99	1.78	2.11	2.93	2.76	4.37	6.66	4.24	7.40
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	1.07	1.02	1.02	0.97	0.80	0.57	0.12	0.01	0.01	0.01
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.12	0.05	-0.22	-0.55	0.78	0.79	24.77	3.91	2.50	5.65
Tax ⓘ	0	0	0	0.64	0.47	0.38	0.62	1.04	1.27	1.45
Profit After Tax	0.12	0.05	-0.22	-1.19	0.31	0.41	24.15	2.87	1.24	4.20
PAT Margin (%)	-	-	-	-	-	-	107.5%	-	-	1,025.2%
Adjusted EPS (₹)	0.1	0.0	-0.2	-1.0	0.3	0.3	19.7	2.3	1.0	3.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	38.35	38.39	37.99	36.81	37.98	36.77	62.94	66.30	65.84	75.65
Share Capital ⓘ	12.24	12.24	12.24	12.24	12.24	12.24	12.24	12.24	12.24	12.24
Reserves ⓘ	26.11	26.15	25.75	24.57	25.74	24.53	50.70	54.06	53.60	63.41
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	0	0	0	0	0	0	0
Others Liabilities ⓘ	-0.42	-0.42	-0.48	0.17	0.39	0.30	0.48	0.51	0.39	0.67
Total Liabilities ⓘ	37.93	37.98	37.51	36.98	38.37	37.07	63.42	66.81	66.23	76.32
Fixed Assets
Gross Block	37.75	37.79	7.42	7.42	6.03	6.03	0.17	0.17	0.17	0.17
Accumulated Depreciation	29.35	30.37	1.02	1.99	1.76	2.33	0.06	0.07	0.08	0.09
Net Fixed Assetsⓘ	8.40	7.42	6.40	5.43	4.27	3.70	0.11	0.10	0.09	0.09
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	27.50	28.01	29.79	10.21	5.93	3.69	8.69	8.82	8.23	8.91
Inventories	1.28	0.98	0.89	0.32	0.31	0.09	0.07	0.15	0	0
Trade Receivables	0	0	0	0	0	0	0	0	0	0.41
Cash Equivalents	0.40	1.23	0.27	0.27	16.33	16.37	11.71	34.22	34.50	0.32
Others Assetsⓘ	0.36	0.34	0.16	20.76	11.52	13.22	42.85	23.53	23.40	66.60
Total Assets ⓘ	37.93	37.98	37.51	36.98	38.37	37.07	63.42	66.81	66.23	76.32

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	0.94	1.08	0.55	-19.79	10.34	-0.63	-27.72	21.91	1.22	-39.31
PBT ⓘ	0.12	0.05	-0.22	-0.55	0.78	0.79	24.77	3.91	2.50	5.65
Adjustment ⓘ	0.83	0.69	0.93	1.48	0.59	0.56	-22.33	-0.01	0	-0.01
Changes in Working Capital ⓘ	0.11	0.32	-0.16	-20.63	9.22	-1.35	-29.48	19.46	-0.21	-43.62
Tax Paid ⓘ	0	0	0	-0.10	-0.25	-0.63	-0.68	-1.45	-1.07	-1.34
Cash Flow From Investing Activity ⓘ	-1.21	-0.26	-1.51	19.78	5.73	0.67	23.06	0.60	-0.94	5.12
Capex	0	-0.04	0	0	0.18	0	25.93	0	0	0
Net Investments	-1.57	-0.52	-1.77	19.58	5.44	0.66	-2.87	0.58	-0.96	5.10
Others ⓘ	0.36	0.30	0.27	0.20	0.11	0.01	0	0.02	0.02	0.02
Cash Flow From Financing Activityⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	-0.27	0.83	-0.95	-0.01	16.07	0.04	-4.66	22.51	0.28	-34.18

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	0.31	0.12	-0.57	-3.18	0.82	1.1	48.44	4.44	1.87	5.94
ROCE (%)	0.31	0.12	-0.57	-1.47	2.07	2.12	49.69	6.05	3.79	7.99
Asset Turnover Ratio	0	0	0	0	0	0	0.45	0	0	0.01
PAT to CFO Conversion(x)	7.83	21.6	N/A	N/A	33.35	-1.54	-1.15	7.63	0.98	-9.36
Working Capital Days
Receivable Days	0	0	0	0	0	0	0	0	0	365
Inventory Days	0	0	0	0	0	0	1	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Transchem Ltd Stock News

Transchem Ltd FAQs

What is the share price of Transchem?

Company share prices are keep on changing according to the market conditions. The closing price of Transchem on 14-Nov-2024 16:59 is ₹38.95.

What is the market cap of Transchem?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 14-Nov-2024 16:59 the market cap of Transchem stood at ₹47.98.

What is the P/E ratio of Transchem?

The latest P/E ratio of Transchem as of 14-Nov-2024 16:59 is 8.73.

What is the P/B ratio of Transchem?

The latest P/B ratio of Transchem as of 14-Nov-2024 16:59 is 0.62.

What is the 52-week high and low of Transchem?

The 52-week high of Transchem is ₹50.69 and the 52-week low is ₹25.01.

What is the TTM revenue of Transchem?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Transchem is ₹0.41 ( Cr.) .

About Transchem Ltd

Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.

The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use APIâ€™s.

The company is having four state of the art GMP approved facilities at multiple locations in India, with total production capacity of 500 MT per annum.

The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India and can meet all the requiered technical and quality aspects of esteemed organizations and is now focusing on Anti-Hypertensive and Anti-Diabetic range of products.

Products and services offered by the company:

Services: